D. Randolph Drosick, MD
As President of OHC, D. Randolph Drosick, MD, guides the practice performance of OHC. Dr. Drosick collaborates with OHC’s doctors and other team members to advance the mission of OHC to deliver high quality, high value cancer care to the people in the communities OHC serves.
Dr. Drosick is a medical oncologist and hematologist. He received his medical degree from West Virginia University, and completed his residency and fellowship at the University of Kentucky, Chandler Medical Center. He is board-certified by the American Board of Internal Medicine in internal medicine and medical oncology. Dr. Drosick specializes in lung cancer and breast cancer, and sees patients at our OHC Eastgate office.
Elizabeth H. Levick, MD
In her role as Chair, Board of Directors, Elizabeth H. Levick, MD, guides board members in their work to evaluate the company’s quality metrics, patient safety, value-based care, and long-term strategy.
Dr. Levick received her medical degree from the University of Toledo/Medical College of Ohio. She completed her residency at Parkland Memorial Hospital, Dallas, Texas, and a fellowship at the University of Cincinnati Medical Center. Dr. Levick is board certified in radiation oncology and specializes in breast cancer, prostate cancer, and brain cancer. She is an expert in the use of Gamma Knife, CyberKnife and radiosurgery. Dr. Levick sees patients at our OHC Kenwood office.
Paul M. Dieter serves as Executive Director for OHC. Paul oversees the strategic planning, growth initiatives and hospital and community collaborations for the organization as well as the daily operations of the multi-specialty oncology and hematology practice. He works closely with OHC’s doctors, management team and The US Oncology Network to identify and implement best practices across the organization.
Paul received a Bachelor of Arts in Business Management from Baldwin Wallace College, Berea, Ohio and a Master of Business Administration from Wilmington University in Dover, Delaware.